SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,693,150 | -28.2% | 13,968 | -32.2% | 0.00% | -25.0% |
| Q2 2023 | $2,357,611 | -30.6% | 20,588 | -16.5% | 0.00% | -33.3% |
| Q1 2023 | $3,398,929 | +214.4% | 24,661 | +196.1% | 0.01% | +200.0% |
| Q4 2022 | $1,081,031 | +133.0% | 8,329 | +97.9% | 0.00% | +100.0% |
| Q3 2022 | $464,000 | +41.0% | 4,209 | -4.4% | 0.00% | 0.0% |
| Q2 2022 | $329,000 | -13.0% | 4,402 | -9.0% | 0.00% | 0.0% |
| Q1 2022 | $378,000 | -20.4% | 4,838 | -8.1% | 0.00% | 0.0% |
| Q4 2021 | $475,000 | -24.4% | 5,263 | -22.6% | 0.00% | 0.0% |
| Q3 2021 | $628,000 | +11.0% | 6,799 | -6.7% | 0.00% | 0.0% |
| Q2 2021 | $566,000 | +13.2% | 7,287 | +8.6% | 0.00% | 0.0% |
| Q1 2021 | $500,000 | -44.7% | 6,709 | +26.5% | 0.00% | -50.0% |
| Q4 2020 | $904,000 | +1.9% | 5,304 | -16.0% | 0.00% | -33.3% |
| Q3 2020 | $887,000 | -3.3% | 6,318 | +10.4% | 0.00% | 0.0% |
| Q2 2020 | $917,000 | +53.9% | 5,724 | -57.4% | 0.00% | +50.0% |
| Q1 2020 | $596,000 | – | 13,424 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |